Sales & Marketing The future is LIVE marketing – and that matters more than ev... Welcome to 2025, world. Think about it: at this same time, just five short years ago, we were in for the ride of our lives, weren’t we?
News Ultragenyx to slash costs after Angelman trial failure Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.